1. Home
  2. KLAC vs MRK Comparison

KLAC vs MRK Comparison

Compare KLAC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLA Corporation

KLAC

KLA Corporation

N/A

Current Price

$156.01

Market Cap

270.0B

Sector

Technology

ML Signal

N/A

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

N/A

Current Price

$144.72

Market Cap

317.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLAC
MRK
Founded
1975
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.0B
317.8B
IPO Year
1994
1997

Fundamental Metrics

Financial Performance
Metric
KLAC
MRK
Price
$156.01
$144.72
Analyst Decision
Buy
Buy
Analyst Count
29
28
Target Price
★ $217.58
$160.29
AVG Volume (30 Days)
7.5M
★ 7.5M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
0.60%
★ 2.29%
EPS Growth
N/A
★ 8.01
EPS
★ 1.18
N/A
Revenue
N/A
★ $65,011,000,000.00
Revenue This Year
$39.01
$3.36
Revenue Next Year
$18.30
$3.40
P/E Ratio
$130.69
★ N/A
Revenue Growth
N/A
★ 1.31
52 Week Low
$144.82
$82.91
52 Week High
$2,431.29
$157.00

Technical Indicators

Market Signals
Indicator
KLAC
MRK
Relative Strength Index (RSI) 38.82 50.33
Support Level $144.82 $140.56
Resistance Level $211.23 $154.35
Average True Range (ATR) 6.27 4.28
MACD -0.10 0.23
Stochastic Oscillator 33.06 43.62

Price Performance

Historical Comparison
KLAC
MRK

About KLAC KLA Corporation

KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: